Healthcare Market News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 360,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "459bbf39-1e35-4afd-851b-5c2ffbc61fd3",
"title": "Cerus announces successful Phase 3 trial for INTERCEPT RBCs By Investing.com",
"description": "Cerus announces successful Phase 3 trial for INTERCEPT RBCs",
"keywords": "",
"snippet": "Published Mar 19, 2024 08:09AM ET\n\n© Reuters.\n\nCERS -2.62% Add to/Remove from Watchlist\n\nCONCORD, Calif. - Cerus (NASDAQ: ) Corporation (NASDAQ:CERS) reported ...",
"url": "https://www.investing.com/news/stock-market-news/cerus-announces-successful-phase-3-trial-for-intercept-rbcs-93CH-3343811",
"image_url": "https://i-invdn-com.investing.com/news/LYNXMPEDAF0IH_L.jpg",
"language": "en",
"published_at": "2024-03-19T12:09:05.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "CERS",
"name": "Cerus Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 76.08445,
"sentiment_score": 0.375483,
"highlights": [
{
"highlight": ". - <em>Cerus</em> (NASDAQ: ) Corporation (<em>NASDAQ:CERS</em>) reported positive results from the ReCePI Phase 3 clinical trial for its INTERCEPT Red Blood Cells (RBCs), marking a significant step in pathogen-reduced blood transfusion therapy.",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Richard Benjamin, <em>Cerus</em>’ chief medical officer, highlighted the ReCePI trial as a pioneering effort in transfusion medicine, providing crucial insights into the efficacy and safety of pathogen-reduced RBCs.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cerus</em> President and CEO William ‘Obi’ Greenman stated that the trial results bring the company closer to potentially offering pathogen reduction for the most commonly transfused blood component in the U.S.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cerus</em> plans for the INTERCEPT RBCs to join its commercial portfolio, which includes INTERCEPT Systems for Platelets, Plasma, and Fibrinogen Complex.\n\nThe ReCePI trial enrolled 581 patients at 18 sites, with 321 requiring RBC transfusions.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "While the system is under development and not yet approved globally, <em>Cerus</em> has filed for a CE Mark in Europe and anticipates FDA submission in the U.S. in the coming years.\n\nThis news is based on a press release statement from <em>Cerus</em> <em>Corporation</em>.\n\nThis article was generated with the support of AI and reviewed by an editor.",
"sentiment": 0.2898,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cerus</em> announces successful Phase 3 trial for INTERCEPT RBCs By Investing.com",
"sentiment": 0.5859,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "0dc87475-5f3d-4220-a0a4-75f23c93eb6a",
"title": "The Art of Valuation: Discovering Thermo Fisher Scientific Inc's Intrinsic Value",
"description": "In this article, we will take a look into Thermo Fisher Scientific Inc's (TMO) DCF analysis, a reliable and data-driven approach to estimating its intrinsic val",
"keywords": "GuruFocus, Article, News, GuruFocus Research, TMO",
"snippet": "In this article, we will take a look into Thermo Fisher Scientific Inc's (TMO, Financial) DCF analysis, a reliable and data-driven approach to estimating its in...",
"url": "https://www.gurufocus.com/news/2386034/the-art-of-valuation-discovering-thermo-fisher-scientific-incs-intrinsic-value",
"image_url": "https://static.gurufocus.com/logos/0C00000CMT.png?12",
"language": "en",
"published_at": "2024-03-19T12:00:17.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TMO",
"name": "Thermo Fisher Scientific Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 109.40477,
"sentiment_score": 0.5909,
"highlights": [
{
"highlight": "In this article, we will take a look into <em>Thermo</em> <em>Fisher</em> <em>Scientific</em> Inc's (TMO, Financial) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "As of 2024-03-19, <em>Thermo</em> <em>Fisher</em> <em>Scientific</em> Inc's intrinsic value as calculated by the Discounted Earnings model is $673.44. It's currently trading at a price of $580.05. Therefore, the margin of safety based on the DCF model is 13.87%. The company is modestly undervalued.",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Thermo</em> <em>Fisher</em> <em>Scientific</em> Inc's intrinsic value estimated by Discounted Earnings model are arrived at by following assumptions and steps.\n\nAssumptions\n\nTerm Value Explanation EPS without NRI $21.55 GuruFocus DCF calculator uses EPS without NRI as the default because historically stock prices are more correlated to earnings than free cash flow.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "This valuation indicates that the <em>Thermo</em> <em>Fisher</em> <em>Scientific</em> <em>Inc</em> is modestly overvalued, accompanied by a margin of safety of -36.89%. You can always switch to using Free Cash Flow per Share to calculate the real DCF model on our DCF calculator page.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "The Art of Valuation: Discovering <em>Thermo</em> <em>Fisher</em> <em>Scientific</em> Inc's Intrinsic Value",
"sentiment": 0.34,
"highlighted_in": "title"
}
]
},
{
"symbol": "TMO.MX",
"name": "Thermo Fisher Scientific Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 109.40215,
"sentiment_score": 0.5909,
"highlights": [
{
"highlight": "In this article, we will take a look into <em>Thermo</em> <em>Fisher</em> <em>Scientific</em> Inc's (TMO, Financial) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "As of 2024-03-19, <em>Thermo</em> <em>Fisher</em> <em>Scientific</em> Inc's intrinsic value as calculated by the Discounted Earnings model is $673.44. It's currently trading at a price of $580.05. Therefore, the margin of safety based on the DCF model is 13.87%. The company is modestly undervalued.",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Thermo</em> <em>Fisher</em> <em>Scientific</em> Inc's intrinsic value estimated by Discounted Earnings model are arrived at by following assumptions and steps.\n\nAssumptions\n\nTerm Value Explanation EPS without NRI $21.55 GuruFocus DCF calculator uses EPS without NRI as the default because historically stock prices are more correlated to earnings than free cash flow.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "This valuation indicates that the <em>Thermo</em> <em>Fisher</em> <em>Scientific</em> <em>Inc</em> is modestly overvalued, accompanied by a margin of safety of -36.89%. You can always switch to using Free Cash Flow per Share to calculate the real DCF model on our DCF calculator page.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "The Art of Valuation: Discovering <em>Thermo</em> <em>Fisher</em> <em>Scientific</em> Inc's Intrinsic Value",
"sentiment": 0.34,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "1a0ce377-a777-4570-a22a-14dd9133e13b",
"title": "Invest with Confidence: Intrinsic Value Unveiled of AbbVie Inc",
"description": "In this article, we will take a look into AbbVie Inc's (ABBV) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of us",
"keywords": "GuruFocus, Article, News, GuruFocus Research, ABBV",
"snippet": "In this article, we will take a look into AbbVie Inc's (ABBV, Financial) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. In...",
"url": "https://www.gurufocus.com/news/2386026/invest-with-confidence-intrinsic-value-unveiled-of-abbvie-inc",
"image_url": "https://static.gurufocus.com/logos/0C00009SSX.png?12",
"language": "en",
"published_at": "2024-03-19T12:00:12.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ABBV",
"name": "AbbVie Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 85.43924,
"sentiment_score": 0.70162,
"highlights": [
{
"highlight": "In this article, we will take a look into <em>AbbVie</em> Inc's (ABBV, Financial) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "As of 2024-03-19, <em>AbbVie</em> Inc's intrinsic value as calculated by the Discounted Earnings model is $198.02. It's currently trading at a price of $178.49. Therefore, the margin of safety based on the DCF model is 9.86%. The company is fair valued.\n\nThe model\n\nThe GuruFocus DCF calculator follows a two-stage model by default.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> Inc's intrinsic value estimated by Discounted Earnings model are arrived at by following assumptions and steps.\n\nAssumptions\n\nTerm Value Explanation EPS without NRI $8.86 GuruFocus DCF calculator uses EPS without NRI as the default because historically stock prices are more correlated to earnings than free cash flow.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "This valuation indicates that the <em>AbbVie</em> <em>Inc</em> is significantly undervalued, accompanied by a margin of safety of 52.85%. You can always switch to using Free Cash Flow per Share to calculate the real DCF model on our DCF calculator page.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Invest with Confidence: Intrinsic Value Unveiled of <em>AbbVie</em> <em>Inc</em>",
"sentiment": 0.6908,
"highlighted_in": "title"
}
]
},
{
"symbol": "ABBV.MX",
"name": "AbbVie Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 85.4397,
"sentiment_score": 0.70162,
"highlights": [
{
"highlight": "In this article, we will take a look into <em>AbbVie</em> Inc's (ABBV, Financial) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "As of 2024-03-19, <em>AbbVie</em> Inc's intrinsic value as calculated by the Discounted Earnings model is $198.02. It's currently trading at a price of $178.49. Therefore, the margin of safety based on the DCF model is 9.86%. The company is fair valued.\n\nThe model\n\nThe GuruFocus DCF calculator follows a two-stage model by default.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AbbVie</em> Inc's intrinsic value estimated by Discounted Earnings model are arrived at by following assumptions and steps.\n\nAssumptions\n\nTerm Value Explanation EPS without NRI $8.86 GuruFocus DCF calculator uses EPS without NRI as the default because historically stock prices are more correlated to earnings than free cash flow.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "This valuation indicates that the <em>AbbVie</em> <em>Inc</em> is significantly undervalued, accompanied by a margin of safety of 52.85%. You can always switch to using Free Cash Flow per Share to calculate the real DCF model on our DCF calculator page.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Invest with Confidence: Intrinsic Value Unveiled of <em>AbbVie</em> <em>Inc</em>",
"sentiment": 0.6908,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "ee30f656-b2b4-4965-a186-8a2326d201d2",
"title": "Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China",
"description": "A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE...",
"keywords": "Nasdaq:CMND, Clearmind Medicine Inc., Patents, IntellectualProperty, amineaminoindan",
"snippet": "A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy\n\nTel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) --...",
"url": "https://www.globenewswire.com/news-release/2024/03/19/2848474/0/en/Breakthrough-in-Wellness-Clearmind-Medicine-s-Psychedelic-Treatment-Granted-Divisional-Patent-Approval-in-China.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/130d7733-5794-4a6b-92bb-1eee23c524f3",
"language": "en",
"published_at": "2024-03-19T11:55:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "CMNDF",
"name": "CLEARMIND MEDICINE INC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 41.57985,
"sentiment_score": 0.1977,
"highlights": [
{
"highlight": "A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy\n\nTel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- <em>Clearmind</em> <em>Medicine</em> <em>Inc</em>.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Clearmind</em> <em>Medicine</em> <em>Inc</em>.\n\nClearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "57dc9170-4b46-4d90-b380-e6f514c08935",
"title": "AVXL INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Anavex Life Sciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit -March 19, 2024",
"description": "Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Anavex Life Sciences Corporation stock between February 1, 2022 and January 1, 2024, both dates inclusive , have until May...",
"keywords": "Markets",
"snippet": "Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Anavex Life Sciences Corporation (NASDAQ: AVXL) stock between February 1, 2022 and Ja...",
"url": "https://www.marketscreener.com/quote/stock/ANAVEX-LIFE-SCIENCES-CORP-24735935/news/AVXL-INVESTOR-DEADLINE-Robbins-Geller-Rudman-Dowd-LLP-Announces-that-Anavex-Life-Sciences-Corpora-46230722/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
"language": "en",
"published_at": "2024-03-19T11:51:02.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "AVXL",
"name": "Anavex Life Sciences Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 72.33928,
"sentiment_score": -0.306725,
"highlights": [
{
"highlight": "Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of <em>Anavex</em> <em>Life</em> <em>Sciences</em> Corporation (<em>NASDAQ</em>: <em>AVXL</em>) stock between February 1, 2022 and January 1, 2024, both dates inclusive (the “Class Period”), have until May 13, 2024 to seek appointment as lead plaintiff of the Anavex class action lawsuit. Captioned Blum v.",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Anavex</em> <em>Life</em> <em>Sciences</em> Corporation, No. 1:24-cv-01910 (S.D.N.Y.), the Anavex class action lawsuit charges Anavex and an Anavex executive with violations of the Securities Exchange Act of 1934.",
"sentiment": -0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered substantial losses and wish to serve as lead plaintiff of the Anavex class action lawsuit, please provide your information here:\n\nhttps://www.rgrdlaw.com/cases-<em>anavex</em>-<em>life</em>-<em>sciences</em>-corporation-class-action-lawsuit-avxl.html\n\nYou can also contact attorneys J.C. Sanchez or Jennifer N.",
"sentiment": -0.25,
"highlighted_in": "main_text"
},
{
"highlight": "AVXL INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that <em>Anavex</em> <em>Life</em> <em>Sciences</em> Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit -March 19, 2024",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "459566c8-0ad5-4ca0-aa4f-7f11554076e4",
"title": "RBC Capital abbassa l'obiettivo delle azioni di Adverum Biotechnologies a causa della \"cautela clinica\".",
"description": "RBC Capital abbassa l'obiettivo delle azioni di Adverum Biotechnologies a causa della",
"keywords": "",
"snippet": "Pubblicato 19.03.2024 12:36\n\n© Reuters.\n\nADVM +4,12% Aggiungi/Rimuovi dal Portafoglio\n\nMartedì, RBC Capital Markets ha modificato l'obiettivo di prezzo delle ...",
"url": "https://it.investing.com/news/stock-market-news/rbc-capital-abbassa-lobiettivo-delle-azioni-di-adverum-biotechnologies-a-causa-della-cautela-clinica-93CH-2304419",
"image_url": "https://i-invdn-com.investing.com/news/LYNXMPEA6S0EV_L.jpg",
"language": "it",
"published_at": "2024-03-19T11:36:26.000000Z",
"source": "it.investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "ADVM",
"name": "Adverum Biotechnologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 85.1195,
"sentiment_score": null,
"highlights": [
{
"highlight": "ADVM +4,12% Aggiungi/Rimuovi dal Portafoglio\n\nMartedì, RBC Capital Markets ha modificato l'obiettivo di prezzo delle azioni di <em>Adverum</em> <em>Biotechnologies</em> (<em>NASDAQ:ADVM</em>) portandolo a 2,00 dollari, in calo rispetto ai precedenti 3,00 dollari, mantenendo un rating Sector Perform sul titolo.",
"sentiment": -0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "RBC Capital abbassa l'obiettivo delle azioni di <em>Adverum</em> <em>Biotechnologies</em> a causa della \"cautela clinica\".",
"sentiment": -0.6486,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "6171dc23-2150-4e96-ad3c-8e8d6b784e73",
"title": "RBC Capital lowers Adverum Biotechnologies shares target amid 'clinical caution' By Investing.com",
"description": "RBC Capital lowers Adverum Biotechnologies shares target amid 'clinical caution'",
"keywords": "",
"snippet": "Published Mar 19, 2024 07:36AM ET\n\n© Reuters.\n\nADVM +4.12% Add to/Remove from Watchlist\n\nTuesday, RBC Capital Markets adjusted the shares price target for Adve...",
"url": "https://www.investing.com/news/stock-market-news/rbc-capital-lowers-adverum-biotechnologies-shares-target-amid-clinical-caution-93CH-3343711",
"image_url": "https://i-invdn-com.investing.com/news/LYNXNPEC0L0PD_L.jpg",
"language": "en",
"published_at": "2024-03-19T11:36:08.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "ADVM",
"name": "Adverum Biotechnologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 78.6596,
"sentiment_score": 0.23695,
"highlights": [
{
"highlight": "ADVM +4.12% Add to/Remove from Watchlist\n\nTuesday, RBC Capital Markets adjusted the shares price target for <em>Adverum</em> <em>Biotechnologies</em> (NASDAQ: ) to $2.00, a decrease from the previous $3.00, while maintaining a Sector Perform rating on the stock. The firm's decision comes in the wake of Adverum's fourth quarter and full-year 2023 financial report.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "RBC Capital lowers <em>Adverum</em> <em>Biotechnologies</em> shares target amid 'clinical caution' By Investing.com",
"sentiment": 0.1779,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "d818bbeb-9a6e-44dc-9e1e-f361a99bc6a5",
"title": "Repligen Appoints Maggie A. Pax to Board of Directors",
"description": "WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life...",
"keywords": "Nasdaq:RGEN, Repligen Corporation",
"snippet": "WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences...",
"url": "https://www.globenewswire.com/news-release/2024/03/19/2848455/24603/en/Repligen-Appoints-Maggie-A-Pax-to-Board-of-Directors.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/967d43f6-7ffd-4ee0-8804-e3c12952402f",
"language": "en",
"published_at": "2024-03-19T11:30:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "THOXF",
"name": "BioPorto A/S",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 32.74533,
"sentiment_score": 0.3818,
"highlights": [
{
"highlight": "She also sits on the board of the U.S. subsidiary of <em>BioPorto</em> <em>A</em>/<em>S</em>, a Danish-based kidney biomarker company. Ms. Pax advises a range of healthcare and life sciences companies on business strategy, commercial growth and partnerships.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DARE",
"name": "Daré Bioscience, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.906162,
"sentiment_score": 0.0772,
"highlights": [
{
"highlight": "Between her Phillips and Thermo Fisher roles, Maggie held a number of entrepreneurial leadership positions, including as Vice President, Business and Clinical Development for five years (2006-2011) at Microchips Biomedical, an MIT startup company that was acquired by <em>Daré</em> <em>Bioscience</em>.\n\nMs.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ALIM",
"name": "Alimera Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.588575,
"sentiment_score": 0.6705,
"highlights": [
{
"highlight": "Pax is currently an independent board director for <em>Alimera</em> <em>Sciences</em>, a Nasdaq-listed pharmaceutical company with retinal treatments, and Jellagen, a privately-held UK company developing novel wound care products. She also sits on the board of the U.S. subsidiary of BioPorto A/S, a Danish-based kidney biomarker company. Ms.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "9e99d97d-b954-451a-b760-60871d29069d",
"title": "lululemon adds former Gap CFO Teri List to Board By Investing.com",
"description": "lululemon adds former Gap CFO Teri List to Board",
"keywords": "",
"snippet": "Published Mar 19, 2024 06:54AM ET\n\n© Reuters.\n\nLULU -1.16% Add to/Remove from Watchlist\n\nVANCOUVER - lululemon athletica inc. (NASDAQ: ) announced the appointm...",
"url": "https://www.investing.com/news/stock-market-news/lululemon-adds-former-gap-cfo-teri-list-to-board-93CH-3343562",
"image_url": "https://i-invdn-com.investing.com/news/LYNXNPED803J6_L.jpg",
"language": "en",
"published_at": "2024-03-19T10:54:46.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "DAP.DE",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 27.085745,
"sentiment_score": 0.9022,
"highlights": [
{
"highlight": "List, who currently also serves on the Boards of Microsoft (NASDAQ: ), Visa (NYSE: ), and <em>Danaher</em> <em>Corporation</em> (NYSE: ), holds both a bachelor's degree in accounting and an honorary doctorate from Northern Michigan University. She expressed her eagerness to support lululemon's growth and to help the company \"continue to live into its vision.\"",
"sentiment": 0.9022,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "33L.DE",
"name": "Lululemon Athletica Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 62.212498,
"sentiment_score": 0.20095,
"highlights": [
{
"highlight": "LULU -1.16% Add to/Remove from Watchlist\n\nVANCOUVER - <em>lululemon</em> <em>athletica</em> <em>inc</em>. (NASDAQ: ) announced the appointment of Teri List, a seasoned executive with extensive experience in finance and retail, to its Board of Directors.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The information is based on a press release statement from <em>lululemon</em> <em>athletica</em> <em>inc</em>.\n\nThis article was generated with the support of AI and reviewed by an editor. For more information see our T&C.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LULU",
"name": "Lululemon Athletica Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 68.61742,
"sentiment_score": 0.20095,
"highlights": [
{
"highlight": "LULU -1.16% Add to/Remove from Watchlist\n\nVANCOUVER - <em>lululemon</em> <em>athletica</em> <em>inc</em>. (NASDAQ: ) announced the appointment of Teri List, a seasoned executive with extensive experience in finance and retail, to its Board of Directors.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The information is based on a press release statement from <em>lululemon</em> <em>athletica</em> <em>inc</em>.\n\nThis article was generated with the support of AI and reviewed by an editor. For more information see our T&C.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MSFT",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 12.605955,
"sentiment_score": 0.9022,
"highlights": [
{
"highlight": "List, who currently also serves on the Boards of <em>Microsoft</em> (NASDAQ: ), Visa (NYSE: ), and Danaher Corporation (NYSE: ), holds both a bachelor's degree in accounting and an honorary doctorate from Northern Michigan University. She expressed her eagerness to support lululemon's growth and to help the company \"continue to live into its vision.\"",
"sentiment": 0.9022,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DHR",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 35.418125,
"sentiment_score": 0.9022,
"highlights": [
{
"highlight": "List, who currently also serves on the Boards of Microsoft (NASDAQ: ), Visa (NYSE: ), and <em>Danaher</em> <em>Corporation</em> (NYSE: ), holds both a bachelor's degree in accounting and an honorary doctorate from Northern Michigan University. She expressed her eagerness to support lululemon's growth and to help the company \"continue to live into its vision.\"",
"sentiment": 0.9022,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DKS",
"name": "DICK'S Sporting Goods, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 33.719154,
"sentiment_score": 0.128,
"highlights": [
{
"highlight": "., <em>DICK'S</em> <em>Sporting</em> <em>Goods</em>, and Kraft Food Group. Her career began in public accounting at Deloitte and included nearly two decades at Procter & Gamble (NYSE: ), where she ultimately served as Senior Vice President and Treasurer.",
"sentiment": 0.128,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LULU.MX",
"name": "Lululemon Athletica Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 62.203575,
"sentiment_score": 0.20095,
"highlights": [
{
"highlight": "LULU -1.16% Add to/Remove from Watchlist\n\nVANCOUVER - <em>lululemon</em> <em>athletica</em> <em>inc</em>. (NASDAQ: ) announced the appointment of Teri List, a seasoned executive with extensive experience in finance and retail, to its Board of Directors.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The information is based on a press release statement from <em>lululemon</em> <em>athletica</em> <em>inc</em>.\n\nThis article was generated with the support of AI and reviewed by an editor. For more information see our T&C.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DHR.MX",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 27.082352,
"sentiment_score": 0.9022,
"highlights": [
{
"highlight": "List, who currently also serves on the Boards of Microsoft (NASDAQ: ), Visa (NYSE: ), and <em>Danaher</em> <em>Corporation</em> (NYSE: ), holds both a bachelor's degree in accounting and an honorary doctorate from Northern Michigan University. She expressed her eagerness to support lululemon's growth and to help the company \"continue to live into its vision.\"",
"sentiment": 0.9022,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2B.L",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 27.085308,
"sentiment_score": 0.9022,
"highlights": [
{
"highlight": "List, who currently also serves on the Boards of Microsoft (NASDAQ: ), Visa (NYSE: ), and <em>Danaher</em> <em>Corporation</em> (NYSE: ), holds both a bachelor's degree in accounting and an honorary doctorate from Northern Michigan University. She expressed her eagerness to support lululemon's growth and to help the company \"continue to live into its vision.\"",
"sentiment": 0.9022,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0JVT.L",
"name": "Lululemon Athletica Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 62.21037,
"sentiment_score": 0.20095,
"highlights": [
{
"highlight": "LULU -1.16% Add to/Remove from Watchlist\n\nVANCOUVER - <em>lululemon</em> <em>athletica</em> <em>inc</em>. (NASDAQ: ) announced the appointment of Teri List, a seasoned executive with extensive experience in finance and retail, to its Board of Directors.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The information is based on a press release statement from <em>lululemon</em> <em>athletica</em> <em>inc</em>.\n\nThis article was generated with the support of AI and reviewed by an editor. For more information see our T&C.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "8dbba9cf-6b28-4369-9226-ecad59540244",
"title": "Teri List Joins lululemon Board of Directors",
"description": "lululemon athletica inc. today announced the appointment of Teri List to serve on its Board of Directors, effective immediately.\n\n\n“Teri’s impressive experience as a business leader and board...",
"keywords": "Markets",
"snippet": "lululemon athletica inc. (NASDAQ: LULU) today announced the appointment of Teri List to serve on its Board of Directors, effective immediately.\n\n“Teri’s imp...",
"url": "https://www.marketscreener.com/quote/stock/LULULEMON-ATHLETICA-INC-40449575/news/Teri-List-Joins-lululemon-Board-of-Directors-46229924/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
"language": "en",
"published_at": "2024-03-19T10:31:02.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "DAP.DE",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 27.085745,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "List currently serves on the Boards of Microsoft, Visa, and <em>Danaher</em> <em>Corporation</em>. She holds a bachelor’s degree in accounting and an honorary doctorate from Northern Michigan University.\n\nAbout lululemon athletica inc.\n\nlululemon athletica inc.",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "33L.DE",
"name": "Lululemon Athletica Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 68.975525,
"sentiment_score": 0.6096,
"highlights": [
{
"highlight": "<em>lululemon</em> <em>athletica</em> <em>inc</em>. (NASDAQ: LULU) today announced the appointment of Teri List to serve on its Board of Directors, effective immediately.",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>lululemon</em> <em>athletica</em> <em>inc</em>.\n\n<em>lululemon</em> <em>athletica</em> <em>inc</em>. (NASDAQ:LULU) is a technical athletic apparel, footwear, and accessories company for yoga, running, training, and most other activities, creating transformational products and experiences that build meaningful connections, unlocking greater possibility and wellbeing for all.",
"sentiment": 0.7425,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LULU",
"name": "Lululemon Athletica Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 102.13197,
"sentiment_score": 0.6096,
"highlights": [
{
"highlight": "<em>lululemon</em> <em>athletica</em> <em>inc</em>. (<em>NASDAQ</em>: <em>LULU</em>) today announced the appointment of Teri List to serve on its Board of Directors, effective immediately.",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>lululemon</em> <em>athletica</em> <em>inc</em>.\n\n<em>lululemon</em> <em>athletica</em> <em>inc</em>. (<em>NASDAQ:LULU</em>) is a technical athletic apparel, footwear, and accessories company for yoga, running, training, and most other activities, creating transformational products and experiences that build meaningful connections, unlocking greater possibility and wellbeing for all.",
"sentiment": 0.7425,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MSFT",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 11.133181,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "List currently serves on the Boards of <em>Microsoft</em>, Visa, and Danaher Corporation. She holds a bachelor’s degree in accounting and an honorary doctorate from Northern Michigan University.\n\nAbout lululemon athletica inc.\n\nlululemon athletica inc.",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DHR",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 27.083347,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "List currently serves on the Boards of Microsoft, Visa, and <em>Danaher</em> <em>Corporation</em>. She holds a bachelor’s degree in accounting and an honorary doctorate from Northern Michigan University.\n\nAbout lululemon athletica inc.\n\nlululemon athletica inc.",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LULU.MX",
"name": "Lululemon Athletica Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 68.96554,
"sentiment_score": 0.6096,
"highlights": [
{
"highlight": "<em>lululemon</em> <em>athletica</em> <em>inc</em>. (NASDAQ: LULU) today announced the appointment of Teri List to serve on its Board of Directors, effective immediately.",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>lululemon</em> <em>athletica</em> <em>inc</em>.\n\n<em>lululemon</em> <em>athletica</em> <em>inc</em>. (NASDAQ:LULU) is a technical athletic apparel, footwear, and accessories company for yoga, running, training, and most other activities, creating transformational products and experiences that build meaningful connections, unlocking greater possibility and wellbeing for all.",
"sentiment": 0.7425,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DHR.MX",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 27.082352,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "List currently serves on the Boards of Microsoft, Visa, and <em>Danaher</em> <em>Corporation</em>. She holds a bachelor’s degree in accounting and an honorary doctorate from Northern Michigan University.\n\nAbout lululemon athletica inc.\n\nlululemon athletica inc.",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2B.L",
"name": "Danaher Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 27.085308,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "List currently serves on the Boards of Microsoft, Visa, and <em>Danaher</em> <em>Corporation</em>. She holds a bachelor’s degree in accounting and an honorary doctorate from Northern Michigan University.\n\nAbout lululemon athletica inc.\n\nlululemon athletica inc.",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0JVT.L",
"name": "Lululemon Athletica Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 68.973206,
"sentiment_score": 0.6096,
"highlights": [
{
"highlight": "<em>lululemon</em> <em>athletica</em> <em>inc</em>. (NASDAQ: LULU) today announced the appointment of Teri List to serve on its Board of Directors, effective immediately.",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>lululemon</em> <em>athletica</em> <em>inc</em>.\n\n<em>lululemon</em> <em>athletica</em> <em>inc</em>. (NASDAQ:LULU) is a technical athletic apparel, footwear, and accessories company for yoga, running, training, and most other activities, creating transformational products and experiences that build meaningful connections, unlocking greater possibility and wellbeing for all.",
"sentiment": 0.7425,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "42062c5a-e979-482c-8c62-e1da83d3c538",
"title": "Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform",
"description": "The proprietary AI-Immunology™ platform brings the potential for a new era in vaccine discovery, design and development using advanced AI and machine...",
"keywords": "Nasdaq:EVAX, Evaxion Biotech, AI, Healthcare Innovation, Vaccines, TechBio, R&D",
"snippet": "The proprietary AI-Immunology™ platform brings the potential for a new era in vaccine discovery, design and development using advanced AI and machine learning...",
"url": "https://www.globenewswire.com/news-release/2024/03/19/2848452/0/en/Evaxion-Hosts-R-D-Day-and-Unveils-the-Broad-Potential-of-Its-AI-Immunology-Platform.html",
"image_url": "https://ml-eu.globenewswire.com/Resource/Download/5dde143b-e9d0-4c17-a4e1-eb65dadb8a7c",
"language": "en",
"published_at": "2024-03-19T11:30:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "EVAX",
"name": "Evaxion Biotech A/S",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 59.3834,
"sentiment_score": 0.245467,
"highlights": [
{
"highlight": "approaches and holds the promise of addressing serious unmet needs\n\nWith a unique modular architecture, AI-Immunology™ is scalable and adaptable towards partner needs\n\nThe potential of AI-Immunology™ is validated by established partnerships, including an ongoing vaccine collaboration with MSD\n\nCOPENHAGEN, Denmark, March 19, 2024 (GLOBE NEWSWIRE) -- <em>Evaxion</em>",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Biotech</em> <em>A</em>/<em>S</em> (<em>NASDAQ</em>: <em>EVAX</em>) (\"Evaxion\" or the \"Company\"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today hosts a Research & Development (R&D) Day focusing on its core AI-Immunology™ platform.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About EVAXION\n\n<em>Evaxion</em> <em>Biotech</em> <em>A</em>/<em>S</em> is a pioneering TechBio company based upon its AI platform, AI-Immunology™. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections.",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "b98335e6-883f-4324-9819-085f1afb9396",
"title": "WuXi AppTec Co., Ltd. : Nomura à l'achat -Le 19 mars 2024 à 12:25",
"description": "Nomura est positif et recommande le titre à l'achat. L'objectif de cours est réduit et passe de 99.16 à 62.75 CNY.",
"keywords": "Bourse",
"snippet": "WuXi AppTec Co., Ltd. est spécialisé dans la fourniture d'un large portefeuille de services de R&D et de fabrication qui permettent aux entreprises des indust...",
"url": "https://www.zonebourse.com/cours/action/WUXI-APPTEC-CO-LTD-44403583/actualite/WuXi-AppTec-Co-Ltd-Nomura-a-l-achat-46230479/",
"image_url": "https://www.zonebourse.com/images/twitter_ZB_fdnoir.png",
"language": "fr",
"published_at": "2024-03-19T11:25:38.000000Z",
"source": "zonebourse.com",
"relevance_score": null,
"entities": [
{
"symbol": "WUXAY",
"name": "WuXi AppTec Co., Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 217.2297,
"sentiment_score": null,
"highlights": [
{
"highlight": "<em>WuXi</em> <em>AppTec</em> <em>Co</em>., <em>Ltd</em>. est spécialisé dans la fourniture d'un large portefeuille de services de R&D et de fabrication qui permettent aux entreprises des industries pharmaceutiques et biotechnologiques de faire progresser les découvertes et de fournir des traitements révolutionnaires aux patients.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>WuXi</em> <em>AppTec</em> <em>Co</em>., <em>Ltd</em>. : Nomura à l'achat -Le 19 mars 2024 à 12:25",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "WUXIF",
"name": "WuXi AppTec Co., Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 217.37,
"sentiment_score": null,
"highlights": [
{
"highlight": "<em>WuXi</em> <em>AppTec</em> <em>Co</em>., <em>Ltd</em>. est spécialisé dans la fourniture d'un large portefeuille de services de R&D et de fabrication qui permettent aux entreprises des industries pharmaceutiques et biotechnologiques de faire progresser les découvertes et de fournir des traitements révolutionnaires aux patients.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>WuXi</em> <em>AppTec</em> <em>Co</em>., <em>Ltd</em>. : Nomura à l'achat -Le 19 mars 2024 à 12:25",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "318ffead-d527-45d8-9237-cd344b5c23e6",
"title": "WuXi AppTec Co., Ltd. : Nomura réitère son opinion positive sur le titre -Le 19 mars 2024 à 12:24",
"description": "Nomura est positif et recommande le titre à l'achat. L'objectif de cours est modifié à la baisse et passe de 86.23 CNY à 54.56 CNY.",
"keywords": "Bourse",
"snippet": "WuXi AppTec Co., Ltd. est spécialisé dans la fourniture d'un large portefeuille de services de R&D et de fabrication qui permettent aux entreprises des indust...",
"url": "https://www.zonebourse.com/cours/action/WUXI-APPTEC-CO-LTD-44403583/actualite/WuXi-AppTec-Co-Ltd-Nomura-reitere-son-opinion-positive-sur-le-titre-46230477/",
"image_url": "https://www.zonebourse.com/images/twitter_ZB_fdblanc.png",
"language": "fr",
"published_at": "2024-03-19T11:24:57.000000Z",
"source": "zonebourse.com",
"relevance_score": null,
"entities": [
{
"symbol": "WUXAY",
"name": "WuXi AppTec Co., Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 187.79535,
"sentiment_score": null,
"highlights": [
{
"highlight": "<em>WuXi</em> <em>AppTec</em> <em>Co</em>., <em>Ltd</em>. est spécialisé dans la fourniture d'un large portefeuille de services de R&D et de fabrication qui permettent aux entreprises des industries pharmaceutiques et biotechnologiques de faire progresser les découvertes et de fournir des traitements révolutionnaires aux patients.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>WuXi</em> <em>AppTec</em> <em>Co</em>., <em>Ltd</em>. : Nomura réitère son opinion positive sur le titre -Le 19 mars 2024 à 12:24",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "WUXIF",
"name": "WuXi AppTec Co., Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 187.91608,
"sentiment_score": null,
"highlights": [
{
"highlight": "<em>WuXi</em> <em>AppTec</em> <em>Co</em>., <em>Ltd</em>. est spécialisé dans la fourniture d'un large portefeuille de services de R&D et de fabrication qui permettent aux entreprises des industries pharmaceutiques et biotechnologiques de faire progresser les découvertes et de fournir des traitements révolutionnaires aux patients.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>WuXi</em> <em>AppTec</em> <em>Co</em>., <em>Ltd</em>. : Nomura réitère son opinion positive sur le titre -Le 19 mars 2024 à 12:24",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "7a891818-b359-4fbb-a859-2fc1a820fb1c",
"title": "Phreesia gets new technology chief (NYSE:PHR)",
"description": "Jack Callahan has been named the new CTO of Phreesia, succeeding Dan Nathan.",
"keywords": "",
"snippet": "To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.\n\nIf you have an ad-blocker enabled you may be blocked from ...",
"url": "https://seekingalpha.com/news/4080938-phreesia-gets-new-technology-chief",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-03-19T11:25:25.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "PHR",
"name": "Phreesia, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 97.21826,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Phreesia</em> gets new technology chief (<em>NYSE:PHR</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "Healthcare",
"total_documents": 813,
"sentiment_avg": 0.23552186846365195
}
]
}
Other details
Entity count
- 11,442